ArticleNeurology(R) neuroimmunology & neuroinflammation2020
Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion.
Abstract readCase Reports
In one paragraph
Article in Neurology(R) neuroimmunology & neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series.Frontiers in neurology · 2024Pooled it
- New autoimmune disorder development after immune reconstitution therapy for multiple sclerosis.Scientific reports · 2024Article
- Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study.Clinical and experimental medicine · 2023Article
- Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination.International journal of molecular sciences · 2023Review
- Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis.Blood advances · 2023Article
- Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis.Therapeutic advances in neurological disorders · 2022Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
John S TzartosFrom the 1st Department of Neurology (J.S.T., D.T., L.S. K.K.), Eginition Hospital, Medical School, National and Kapodistrian University of Athens (NKUA); Tzartos NeuroDiagnostics (J.S.T., C.S., M.D.); Blood Transfusion Department (S.V.), Aretaieion Hospital, Medical School, NKUA; Hematology Division (D.B.), Alexandra General Hospital; Department of Clinical Therapeutics (E.P.), Medical School, NKUA, and 2nd Department of Radiology (G.V.), Medical School, NKUA, Athens, Greece. jtzartos@gmail.com.
Serena ValsamiFrom the 1st Department of Neurology (J.S.T., D.T., L.S. K.K.), Eginition Hospital, Medical School, National and Kapodistrian University of Athens (NKUA); Tzartos NeuroDiagnostics (J.S.T., C.S., M.D.); Blood Transfusion Department (S.V.), Aretaieion Hospital, Medical School, NKUA; Hematology Division (D.B.), Alexandra General Hospital; Department of Clinical Therapeutics (E.P.), Medical School, NKUA, and 2nd Department of Radiology (G.V.), Medical School, NKUA, Athens, Greece.
Dimitrios TzanetakosFrom the 1st Department of Neurology (J.S.T., D.T., L.S. K.K.), Eginition Hospital, Medical School, National and Kapodistrian University of Athens (NKUA); Tzartos NeuroDiagnostics (J.S.T., C.S., M.D.); Blood Transfusion Department (S.V.), Aretaieion Hospital, Medical School, NKUA; Hematology Division (D.B.), Alexandra General Hospital; Department of Clinical Therapeutics (E.P.), Medical School, NKUA, and 2nd Department of Radiology (G.V.), Medical School, NKUA, Athens, Greece.
Christos StergiouFrom the 1st Department of Neurology (J.S.T., D.T., L.S. K.K.), Eginition Hospital, Medical School, National and Kapodistrian University of Athens (NKUA); Tzartos NeuroDiagnostics (J.S.T., C.S., M.D.); Blood Transfusion Department (S.V.), Aretaieion Hospital, Medical School, NKUA; Hematology Division (D.B.), Alexandra General Hospital; Department of Clinical Therapeutics (E.P.), Medical School, NKUA, and 2nd Department of Radiology (G.V.), Medical School, NKUA, Athens, Greece.
Maria DandoulakiFrom the 1st Department of Neurology (J.S.T., D.T., L.S. K.K.), Eginition Hospital, Medical School, National and Kapodistrian University of Athens (NKUA); Tzartos NeuroDiagnostics (J.S.T., C.S., M.D.); Blood Transfusion Department (S.V.), Aretaieion Hospital, Medical School, NKUA; Hematology Division (D.B.), Alexandra General Hospital; Department of Clinical Therapeutics (E.P.), Medical School, NKUA, and 2nd Department of Radiology (G.V.), Medical School, NKUA, Athens, Greece.
Despina BarbarousiFrom the 1st Department of Neurology (J.S.T., D.T., L.S. K.K.), Eginition Hospital, Medical School, National and Kapodistrian University of Athens (NKUA); Tzartos NeuroDiagnostics (J.S.T., C.S., M.D.); Blood Transfusion Department (S.V.), Aretaieion Hospital, Medical School, NKUA; Hematology Division (D.B.), Alexandra General Hospital; Department of Clinical Therapeutics (E.P.), Medical School, NKUA, and 2nd Department of Radiology (G.V.), Medical School, NKUA, Athens, Greece.
Erasmia PsimenouFrom the 1st Department of Neurology (J.S.T., D.T., L.S. K.K.), Eginition Hospital, Medical School, National and Kapodistrian University of Athens (NKUA); Tzartos NeuroDiagnostics (J.S.T., C.S., M.D.); Blood Transfusion Department (S.V.), Aretaieion Hospital, Medical School, NKUA; Hematology Division (D.B.), Alexandra General Hospital; Department of Clinical Therapeutics (E.P.), Medical School, NKUA, and 2nd Department of Radiology (G.V.), Medical School, NKUA, Athens, Greece.
Georgios VelonakisFrom the 1st Department of Neurology (J.S.T., D.T., L.S. K.K.), Eginition Hospital, Medical School, National and Kapodistrian University of Athens (NKUA); Tzartos NeuroDiagnostics (J.S.T., C.S., M.D.); Blood Transfusion Department (S.V.), Aretaieion Hospital, Medical School, NKUA; Hematology Division (D.B.), Alexandra General Hospital; Department of Clinical Therapeutics (E.P.), Medical School, NKUA, and 2nd Department of Radiology (G.V.), Medical School, NKUA, Athens, Greece.
Leonidas StefanisFrom the 1st Department of Neurology (J.S.T., D.T., L.S. K.K.), Eginition Hospital, Medical School, National and Kapodistrian University of Athens (NKUA); Tzartos NeuroDiagnostics (J.S.T., C.S., M.D.); Blood Transfusion Department (S.V.), Aretaieion Hospital, Medical School, NKUA; Hematology Division (D.B.), Alexandra General Hospital; Department of Clinical Therapeutics (E.P.), Medical School, NKUA, and 2nd Department of Radiology (G.V.), Medical School, NKUA, Athens, Greece.
Konstantinos KilidireasFrom the 1st Department of Neurology (J.S.T., D.T., L.S. K.K.), Eginition Hospital, Medical School, National and Kapodistrian University of Athens (NKUA); Tzartos NeuroDiagnostics (J.S.T., C.S., M.D.); Blood Transfusion Department (S.V.), Aretaieion Hospital, Medical School, NKUA; Hematology Division (D.B.), Alexandra General Hospital; Department of Clinical Therapeutics (E.P.), Medical School, NKUA, and 2nd Department of Radiology (G.V.), Medical School, NKUA, Athens, Greece.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAlemtuzumabAnemia, Hemolytic, AutoimmuneAquaporin 1AutoantibodiesHumansImmunologic FactorsMultiple SclerosisMyelitis, TransverseRecurrenceAlemtuzumabAQP1 protein, humanAquaporin 1AutoantibodiesImmunologic Factors
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.